In a report released today, James Orsborne from Stifel Nicolaus maintained a Hold rating on Haleon PLC (HLN – Research Report), with a price target of p370.00.
James Orsborne’s rating is based on Haleon PLC’s solid performance and strong fundamentals, which position it as a quality stock in the consumer healthcare sector. Despite these strengths, the stock is currently trading at a premium compared to its peers, limiting the potential for further upside unless there is a significant increase in growth.
Orsborne anticipates that Haleon will meet its 2024 expectations, but notes that the company’s growth projections for 2025 are at the lower end of consensus estimates. The current valuation appears justified only if Haleon can achieve growth at the higher end of its guidance range. Consequently, Orsborne maintains a Hold rating, suggesting investors wait for a clearer growth trajectory or a more favorable entry point.